Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Clinical trial NCT00336479 · COMPLETED

Trial details

NCT number: NCT00336479
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2006-06-01
Primary completion: 2008-02-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.